Jerash Holdings (US) Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Jerash Holdings (US) in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Jerash Holdings (US) stock.
View analyst ratings for Jerash Holdings (US) or view top-rated stocks.

Wall Street analysts have given Jerash Holdings (US) a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Jerash Holdings (US) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Jerash Holdings (US) saw a increase in short interest in February. As of February 12th, there was short interest totaling 7,500 shares, an increase of 200.0% from the January 28th total of 2,500 shares. Based on an average daily volume of 21,500 shares, the short-interest ratio is currently 0.3 days. Currently, 0.3% of the shares of the company are sold short.
View Jerash Holdings (US)'s Short Interest.

Jerash Holdings (US) is scheduled to release its next quarterly earnings announcement on Monday, July 5th 2021.
View our earnings forecast for Jerash Holdings (US).

Jerash Holdings (US), Inc. (NASDAQ:JRSH) issued its quarterly earnings data on Wednesday, February, 10th. The company reported $0.01 earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.03. Jerash Holdings (US) had a trailing twelve-month return on equity of 8.45% and a net margin of 5.49%.
View Jerash Holdings (US)'s earnings history.

Jerash Holdings (US)'s stock was trading at $5.79 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, JRSH stock has increased by 2.1% and is now trading at $5.91.
View which stocks have been most impacted by COVID-19.

Jerash Holdings (US) declared a quarterly dividend on Friday, February 5th. Shareholders of record on Tuesday, February 16th will be paid a dividend of $0.05 per share on Tuesday, February 23rd. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.38%. The ex-dividend date of this dividend is Friday, February 12th.
View Jerash Holdings (US)'s dividend history.

Jerash Holdings (US) pays an annual dividend of $0.20 per share and currently has a dividend yield of 3.26%. Jerash Holdings (US) does not yet have a strock track record of dividend growth. The dividend payout ratio of Jerash Holdings (US) is 35.09%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Jerash Holdings (US) will have a dividend payout ratio of 30.77% next year. This indicates that Jerash Holdings (US) will be able to sustain or increase its dividend.
View Jerash Holdings (US)'s dividend history.

Jerash Holdings (US) updated its fourth quarter 2021 Pre-Market earnings guidance on Wednesday, February, 10th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $20 million, compared to the consensus revenue estimate of $22.47 million.

1 brokerages have issued twelve-month price targets for Jerash Holdings (US)'s stock. Their forecasts range from $8.00 to $8.00. On average, they expect Jerash Holdings (US)'s share price to reach $8.00 in the next year. This suggests a possible upside of 35.4% from the stock's current price.
View analysts' price targets for Jerash Holdings (US) or view top-rated stocks among Wall Street analysts.

Some companies that are related to Jerash Holdings (US) include Ever-Glory International Group (EVK), Sequential Brands Group (SQBG), Simon Worldwide (SWWI), Centric Brands (CTRCQ), Blue (BLHI), Panglobal Brands (PNGB) and Tandy Brands Accessories (TBACQ).
View all of JRSH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Jerash Holdings (US) investors own include Pfizer (PFE), (PRMW), AbbVie (ABBV), Ampio Pharmaceuticals (AMPE), Applied DNA Sciences (APDN), Brainstorm Cell Therapeutics (BCLI), Bionano Genomics (BNGO), ChromaDex (CDXC), Chimerix (CMRX) and Cinemark (CNK).

Jerash Holdings (US) trades on the NASDAQ under the ticker symbol "JRSH."

Jerash Holdings (US)'s stock is owned by many different retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (0.89%) and BlackRock Inc. (0.11%).
View institutional ownership trends for Jerash Holdings (US).

JRSH stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, and BlackRock Inc..
View insider buying and selling activity for Jerash Holdings (US) or or view top insider-buying stocks.

Shares of JRSH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of JRSH stock can currently be purchased for approximately $5.91.

Jerash Holdings (US) has a market capitalization of $66.93 million and generates $93.02 million in revenue each year. The company earns $6.46 million in net income (profit) each year or $0.57 on an earnings per share basis.

Jerash Holdings (US) employs 4,200 workers across the globe.

The official website for Jerash Holdings (US) is www.jerashholdings.com.

Jerash Holdings (US) is headquartered at 260 EAST MAIN STREET SUITE 2706, ROCHESTER NY, 14604.

Jerash Holdings (US)'s mailing address is 260 EAST MAIN STREET SUITE 2706, ROCHESTER NY, 14604. The company can be reached via phone at 214-906-0065 or via email at [email protected]